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Objective: The purpose of this study was to evaluate the effect of preoperative coil embolization of lumbar and inferior
mesenteric arteries on the incidence of type II endoleak after endovascular abdominal aortic aneurysm repair.
Methods: The subjects were consecutive patients who underwent EVAR between January 1996 and January 2001. Patent
aortic side branches were identified with preprocedural spiral computed tomographic scanning and calibrated angiogra-
phy. Coil embolization was performed before EVAR. Patients were followed up with plain radiographs and ultrasound
and dual phase spiral computed tomographic scans. Digital subtraction angiography was performed when endoleak was
suspected. The outcome measures were the incidence of type II endoleaks and changes in maximum aortic sac diameter
(Dmax).
Results: Forty patients underwent EVAR, with a median duration of follow-up of 24 months (range, 3 to 48 months).
Before surgery, the inferior mesenteric artery was patent in 16 patients (45%) and the lumbar arteries in 21 patients (53%).
Inferior mesenteric artery embolization was successful in 13 of 16 patients (81%). Lumbar embolization was attempted
in 13 patients and was successful in eight (62%). During EVAR, successful sac exclusion was achieved in 38 patients (95%).
None of the patients who underwent embolization before EVAR had type II endoleak develop, eight of 13 patients (62%)
with patent lumbar arteries had endoleaks develop (P  .006), and three of these patients subsequently underwent
successful coil embolization. Type II endoleak was associated with a 2.0-mm median increase in Dmax (P  .045). A
3.0-mm median reduction in Dmax was seen in the absence of type II endoleak (P  .002).
Conclusion: Type II endoleaks are predictable, preventable, and sometimes treatable. Significant sac shrinkage occurs in
the absence of lumbar endoleak but not in the presence of type II endoleak. (J Vasc Surg 2002;36:105-10.)
Endoleak is a complication specific to endovascular
abdominal aortic aneurysm repair (EVAR) and has been
defined as blood flow outside the stent graft but within the
aneurysm sac.1 Aortic branch vessels (inferior mesenteric
artery [IMA] and lumbar arteries) form potential commu-
nications between the aneurysm sac and the systemic circu-
lation. Type II branch vessel endoleaks can transmit pres-
sure into the aneurysm sac.2 Malina et al3 noted that even
minor endoleak or collateral perfusion inhibits sac shrink-
age. More recently, both in vitro and clinical studies have
shown pulsatile systemic pressure within the aneurysm sac
in the presence of type II endoleak.4,5 Cases of type II
endoleak causing both sac growth and rupture also have
been reported.6-9 Type II endoleaks have been considered
relatively benign,10 but these results indicate their clinical
importance. Recent evidence indicates the correlation be-
tween side branch patency and type II endoleak.11,12 Pre-
operative occlusion of these branches may prevent the
subsequent development of type II endoleak.
MATERIALS AND METHODS
Design. This study was conducted as a prospective
intervention study set in a university teaching hospital.
Patient selection. The study population comprised
consecutive patients with abdominal aortic aneurysm who
underwent EVAR between September 1996 and April
2001. For determination of suitability, patients for EVAR
underwent screening with dynamically enhanced spiral
computed tomographic (CT) scan and digital subtraction
angiography with a calibrated catheter. Patients suitable for
EVAR had stent grafts sized according to manufacturer
recommendations. All scans were reviewed by at least two
vascular radiologists (DK, IR, JP), and patent aortic side
branches (IMA and lumbar arteries) were noted. Patency
was defined as evidence of perfusion of the vessel from
the aortic lumen. For the purpose of the study, we
defined a significantly sized lumbar vessel as being ame-
nable to catheterization with a 4F or 5F catheter (ie,
measuring approximately1.5 mm in diameter). Embo-
lization was only attempted in lumbar arteries considered
amenable to catheterization (ie, those measuring ap-
proximately 1.5 mm in diameter).
Preoperative coil embolization of aortic side
branches. Preoperative embolization was performed be-
fore EVAR using 2-mm to 5-mm coils to occlude the target
artery. In the IMA, coils were deployed proximal to the left
colic artery (Fig 1). Currently, we attempt embolization in
all patients with significantly sized patent lumbar arteries
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lying outside the aneurysm neck. In our early experience, this
was not routine, hence lumbar artery embolization was not
attempted in all patients. Technical success was defined as
angiographic occlusion of the IMA or all target lumbar arter-
ies.
Endovascular aortic aneurysm repair. EVAR was
performed with general anesthesia in an interventional ra-
diology suite with operating room conditions. Vanguard I
(Boston Scientific, St Albans, UK), AneuRx (Medtronic,
Watford, UK), and Excluder (Gore, Livingston, UK) stent
grafts were used. Graft deployment was performed by a
combined team of vascular radiologists and surgeons.
Completion angiography was performed to check for en-
doleaks. Thirty-day morbidity and mortality were docu-
mented in all patients.
Follow-up assessment. Patients were followed with
plain radiographs and ultrasound and dual-phase contrast
enhanced CT scans. Dynamically enhanced scans were
commenced 30 seconds after the start of contrast infusion,
and delayed scans taken 30 seconds later during venous
phase enhancement. Scans were reviewed for evidence of
patent branch arteries, endoleak, and maximum external
diameter of the aneurysm sac. Diameters were measured by
hand with mechanical calipers on the hard copy images.
The greatest transverse diameter of the aneurysm sac
(Dmax) was recorded. When the aneurysm sac was elliptic,
the short axis measurement also was recorded. When an
apparent increase was found in Dmax, comparison was
made between scans to ensure that a comparable level was
assessed and a reproducible measurement had been taken.
Time of occurrence of type II endoleak was defined as the
first instance of demonstrable sac perfusion on CT or
ultrasound scan in the absence of a graft-related endoleak.
Scans were performed before discharge and at 1, 3, 6, 12,
18, and 24 months and annually thereafter. Results were
recorded on a database (DK, LD, DJAS). The site of origin
of all leaks was confirmed with angiography, including, if
necessary, selective ipsilateral hypogastric artery angiogra-
phy. Endoleaks were classified as immediate (present from
stent graft deployment), early (detected within 30 days of
EVAR), or delayed (detected after 1 month during follow-
up). Persistent endoleaks were defined as being detectable
on at least two consecutive follow-up scans, at least 3
months apart.
Secondary intervention. Embolization was at-
tempted in patients with persistent lumbar endoleaks with-
out shrinkage of the aneurysm sac. The ipsilateral hypogas-
tric artery was catheterized with a 5F catheter, and access to
the target lumbar artery was obtained with a coaxial micro-
catheter (Fig 2). Coils were deployed as close to the aneu-
rysm sac as possible. In most cases, multiple Gianturco coils
were deployed in the inflow vessel. If catheterization of the
target vessel was impossible, then the feeding vessels were
embolized. When collateral vessels perfused the adjacent
lumbar arteries, the entire ileolumbar trunk was occluded.
Glue (N-butyl 2-cyanoacrylate) embolization was per-
formed in a single patient in whom catheterization of the
right fourth lumbar artery, which fed the endoleak, was
impossible. Particulate embolization was not used. Success
was defined as abolition of the endoleak on angiography
and subsequent imaging studies.
Outcome measures. The primary outcome measure
was the incidence of type II endoleak. Secondary outcome
measures were the technical success rate of preoperative
and postoperative embolization and change in the Dmax.
Statistical analysis. All data were analyzed with SPSS
for Windows version 9.0 (SPSS, Inc, Chicago, Ill). Cate-
goric data were analyzed with a two-tailed Fisher exact test
for the difference in proportions of type II endoleak in
those cases with successful embolization as compared with
those with patent side branches at baseline. Nonparametric
data were analyzed with Wilcoxon matched pairs signed
rank test for changes in Dmax.
RESULTS
Forty patients (34 male, six female) underwent treat-
ment with EVAR, with Vanguard I, AneuRx, and Excluder
stent grafts deployed in five, 33, and two patients, respec-
tively. Median age was 75.6 years (range, 54 to 92 years).
Twenty-seven patients (67.5%) had patent IMA or lumbar
arteries (Table I shows the prevalence of patent branch
vessels on preoperative imaging).
Preoperative embolization. Nineteen of the 27 pa-
tients with patent aortic side branches underwent at-
tempted preoperative embolization. The procedures typi-
cally took between 30 and 60 minutes and were without
complication. Technical success was defined as angiographic
occlusion of the IMA or all target lumbar arteries. All
successful lumbar vessel embolization involved coil deploy-
ment in the larger fourth and third lumbar arteries. The
median number of lumbar vessels embolized was two
(range, 1 to 5). Embolization was successful in 14 patients
(74%), and 21 target vessels (78%) were occluded.
Endovascular aneurysm repair. Successful aneurysm
exclusion was achieved in 38 of 40 patients (95%). One
immediate type III endoleak with no demonstrable outflow
vessel was seen. The leak was the result of a tiny “pinhole-
like” defect in the fabric of the right iliac limb. A single type
II endoleak was associated with a solitary patent lumbar
artery. Both settled spontaneously by 30 days and did not
recur during follow-up. The 30-day mortality rate was four
of 40 (10%). Two deaths occurred after resections for
colonic malignant disease 2 weeks after EVAR. The need
for major abdominal surgery had been an indication for
Table I. Patent aortic side braches at presentation
Patent vessels at presentation No.
IMA 16 (45%)
All lumbar arteries* 21 (53%)*
IMA and lumbar 10 (25%)
IMA and/or lumbar 27 (67.5%)
*Of 21 patients with patent lumbar arteries, 19 (90%) had a patent fourth
lumbar artery; 7 (33%) had a patent fourth and second/third lumbar artery;
and 2 (10%) had a patent third lumbar artery alone.
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EVAR in these patients, and in each case, recovery after the
aneurysm repair was uneventful. The third patient died of
cholecystitis associated with cardiac failure on the 30th
postoperative day. The fourth died of small bowel infarc-
tion 48 hours after EVAR. A subsequent postmortem
examination revealed extensive atheroma in the suprarenal
aorta, and the superior mesenteric artery was patent. Patchy
small intestinal infarction was thought to have arisen from
massive embolization of atheromatous debris during stent
deployment. These latter two patients were octogenarians
and were classified as unfit for open aneurysm repair. In
addition, both patients had large aneurysms with short
markedly angulated proximal aneurysm necks. Both proce-
dures were complex and necessitated placement of addi-
tional proximal cuffs. These four patients were all excluded
from the subsequent analysis.
Follow-up. The median follow-up period for all pa-
tients (n  36) was 24 months (range, 6 to 48 months),
and follow-up periods of the patients with and without
embolization were 24 months (range, 6 to 48 months) and
30 months (range, 18 to 36 months), respectively. The
incidence rate of lumbar endoleak was eight of 36 (22%)
during follow-up (Table II). The median time of lumbar
endoleak detection was 9 months (range, 1 to 18 months).
All endoleaks persisted on at least two consecutive scans.
Seven endoleaks were detected with CT scan, and one with
duplex scan. All endoleaks arose from the third or fourth
lumbar arteries and had a patent outflow source. Two
patients (6%) had a type I endoleak develop (one proximal,
one distal), and one patient (3%) a type III endoleak. One
patient (3%) with an inflammatory aneurysm had an aor-
toduodenal fistula develop at 6 months that needed stent
graft replacement with an in situ silver impregnated graft.13
These patients were all excluded from statistical analysis of
changes in sac size.
Effect of preoperative embolization on incidence of
type II endoleak. No type II endoleaks were seen among
patients who had spontaneously occluded aortic side
branches at baseline (n 13) or who underwent successful
IMA or lumbar embolization (n 14). No IMA endoleaks
were found. Eight of 13 patients (62%) with patent lumbar
arteries had a subsequent lumbar endoleak develop, com-
pared with none of the eight patients (0%) who had under-
gone preoperative lumbar embolization (P  .006, Fisher
exact test).
Changes in maximum sac diameter at follow-up.
Changes in Dmax are illustrated in Fig 3. In the absence of
lumbar endoleak, a mean reduction of 3.0 mm (interquar-
tile range, 10.5-0) was seen in Dmax (P  .002). In the
presence of lumbar endoleak, a 2.0-mm median increase
(interquartile range, 0-5.0) in Dmax was seen (P  .045),
and three of these eight patients (38%) underwent aneu-
rysm sac growth of 5 mm or more.
Secondary intervention. Changes in Dmax and the
outcome of secondary intervention in patients with lumbar
endoleak are shown in Table II. Only three of six patients
(50%) had successful treatment with coil embolization
compared with 14 of 19 patients (74%) before surgery (P
.344). Postoperative embolization took longer than preop-
erative embolization, typically in excess of 2 hours. Embo-
lization was initially unsuccessful in one patient with a
high-grade stenosis at the origin of the ileolumbar trunk.
Table II. Patients with lumbar endoleak: origin, changes in sac size, and outcome of secondary intervention
Case
Source
inflow3
outflow
Time when
detected
(mo)
 Dmax
(mm)
Secondary
embolization
Further interventions or
events  Dmax2
1 L L43
R L4
18 6 Failed
embolization
Successful
embolization‡
–3
2 L L33
R L4
6 0 Awaiting
embolization
3 L L43
R L4
12 5 Died before
intervention†
4 R L43
L L4
6 2 Failed
embolization*
0
5 R L43
L L3/4
12 0 Successful
embolization
–7
6 L L43
R L4
1 2 Failed
embolization
Died during follow-up†
7 R L43
L L4.
12 1 Successful
embolization
–1
8 L L43
R L4
3 5 Successful
embolization
Died during follow-up†
Median 9 2 Success rate
3/6 (50%)
*Unable to traverse aneurysm sac. Inflow vessel only embolized.
†All deaths were unrelated to stent grafting.
‡Laproscopic clipping failed, followed by successful second attempt at embolization.
L3, third lumbar artery; L4, fourth lumbar artery; R, right; L, left; Dmax, change in maximum sac diameter before secondary intervention; Dmax2, change
in sac diameter after secondary intervention.
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The endoleak leak was eventually occluded via the con-
tralateral ileolumbar trunk at a second embolotherapy ses-
sion. In the patients in whom coil embolization was suc-
cessful, reductions were seen in Dmax of1 mm,3 mm,
and 7 mm (Fig 4).
Complications. No complications were seen related to
preoperative embolization. A patient who underwent embo-
lization with cyanoacrylate had a foot drop develop as the result
of sciatic nerve palsy.
DISCUSSION
Reduction in size of the aneurysm sac is the only absolute
indication of stent graft treatment success.10,14-16 In the pres-
ence of type II lumbar endoleak, we observed a small but
statistically significant increase in sac diameter. In the recent
series from Gould et al,17 four of 14 patients (29%) with type
II endoleak had a more than 5 mm increase in sac diameter,
which is similar to the 38% in our experience. Sac expansion is
in keeping with the observation from Baum et al2 that type II
endoleaks are perfused at near arterial pressure. In contrast,
some studies have failed to show a significant change in
aneurysm sac size in the presence of type II endoleak.10,14
Detection of small changes in aneurysm size can be problem-
atic. Previous work has highlighted potential problems with
repeatability of measurements of aneurysm diameter.18,19
Lederle et al19 have suggested that agreement to within 1
mm can be achieved when a consistent measuring tech-
nique is adopted. We have endeavoured to make measure-
ments as objective and reproducible as possible by limiting
reporting of CT scans to vascular radiologists and using
mechanical callipers for all measurements. For prevention of
bias, all measurements were made without knowledge of
previous results. An audit of our technique has shown it to be
accurate and reproducible.
Fig 1. Carbon dioxide digital subtraction angiograms. A, Lateral
flush aortogram during embolization. Coils (black arrow) are
clearly seen in IMA. B, Aortogram in anteroposterior projection
after EVAR. Image shows retrograde filling of IMA (white arrows)
from superior mesenteric artery via left colic artery. Embolization
coils (black arrows) prevent retrograde perfusion of aneurysm sac.
Fig 2. A, Image obtained during embolization of endoleak.
Catheter (5F; black arrow) has been positioned in left hypogastric
artery. Microcatheter (3F; white arrows) has been maneuvered via
left iliolumbar trunk into right fourth lumbar artery. B, Carbon
dioxide digital subtraction angiogram after embolization. Coils
were deployed backwards from right fourth lumbar artery into left
fourth lumbar artery (white arrows). Flow is preserved in left
iliolumbar trunk and distal left fourth lumbar artery (black arrows).
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Type II endoleaks are frequently observed and account
for between 18% and 30% of all endoleaks.20-22 In our series,
despite the use of preoperative embolization, eight of 36
patients (22%) had lumbar endoleak develop. Without em-
bolization, the observed endoleak rate likely would have
been even greater. Increased rates of endoleak detection in
this series might be the result of the combination of rigor-
ous follow-up with dual phase CT and ultrasound scans,
combined with a high index of suspicion. Our endoleak rate
is comparable with the rate of recent work that has also used
dual phase CT scan.11,17,23
Reduction of the incidence rate of type II endoleaks seems
desirable. Recent work from Fan et al11 and Gorich et al12 has
shown the influence of the number of patent branch vessels in
the prediction of type II endoleak. In our series, no endoleaks
were seen in the absence of patent side branches. This con-
trasts starkly with an endoleak rate of 62% in those with patent
lumbar arteries. We successfully performed preoperative coil
embolization in about three quarters of all patients without
any procedural complications. Failure was usually attributable
to unfavorable anatomic considerations, particularly the pres-
ence of luminal thrombus. In our series, adoption of a policy
of preoperative embolization of all significant third and fourth
lumbar arteries significantly reduced the incidence rate of
lumbar endoleak. Most significantly sized lumbar vessels (19/
21; 91%) were fourth lumbar. Common sense dictates that
these larger vessels are more likely to remain patent after stent
deployment. Gould et al17 reported no difference in the
incidence rate of type II endoleak after preoperative emboli-
zation and concluded that the procedure was ineffective.
Gould et al17 included small lumbar arteries in his “nonem-
bolized” group. If these vessels were irrelevant, this would
reduce the observed incidence rate of endoleak in the nonem-
bolization group. Successful treatment in our series was de-
fined as coil embolization of all target vessels. Gould et al17
included patients with incomplete embolization as a technical
success. If significant lumbar vessels remain patent, than this
will tend to increase the observed incidence rate of endoleak in
the embolized group.
All but one of the lumbar endoleaks we observed were
delayed in onset, with detection after a median of 9 months
of follow-up (range, 1 to 18 months). Some lumbar en-
doleaks may be present immediately after stent grafting but
are only detected later with progressive enlargement.
Equally, some endoleaks might be intermittent or occur
with recanalization of an occluded artery. Late endoleaks
likely represent a true de novo development, as observed by
Gould et al,17 because none of the new endoleaks was
demonstrable on review of the previous scans. That none of
the type II endoleaks that we observed resolved spontane-
ously is surprising.24 In our experience, all of the lumbar
endoleaks had demonstrable outflow vessels, suggesting
that branch-to-branch circuits are necessary to maintain
type II endoleaks. Our results suggest that these circuits
have arisen in those patients in whom embolization was not
attempted or was unsuccessful. Lumbar arteries arising from
the aneurysm neck are likely to thrombose spontaneously
because no space exists between the graft and the aortic wall.
Fig 3. Box whiskerplot shows median changes in sac size (Dmax)
in patients with and without lumbar endoleak.
Fig 4. Late phase contrast-enhanced CT scans. A, Scan shows
type II lumbar endoleak. Enhancement is seen within aneurysm sac
(white arrows) both anterior and posterior to stent graft. Feeding
right fourth lumbar artery (black arrows) can be seen adjacent to
vertebral body. B, Corresponding image 3 months after coil em-
bolization. Coils are seen in right fourth lumbar artery (black
arrows), aneurysm has decreased in size, and perfusion of sac no
longer exists.
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Ermis et al25 have shown that successful embolization
of patients with perigraft and collateral endoleaks can pre-
cipitate sac shrinkage. Once a type II endoleak has devel-
oped it can be treated with a variety of techniques.2,24-28
Embolization of established type II endoleak is a techni-
cally demanding and time-consuming procedure, with
some patients needing more than one session to achieve
occlusion. Our technical success rate with post-EVAR em-
bolization was only three of six (50%), which is comparable
with other series.25 After successful treatment of the en-
doleak, sac shrinkage occurred in every case, indicating
significant pressurization of the sac.
Alternative therapeutic options include the use of liq-
uid embolic agents, but these increase the risk of the
procedure. The sole neurologic complication of embolo-
therapy in our experience has been the patient with sciatic
nerve palsy after glue embolization. In this patient, selective
catheterization of the lumbar artery to deploy coils was
impossible, and nontarget embolization occurred. Both
sciatic and femoral nerve damage have been reported as a
result of using particulate or liquid embolic agents in the
pelvic circulation, particularly in the posterior division of
the hypogastric artery.29
CONCLUSION
Patent aortic side branches are associated with type II
endoleaks and aneurysm growth. In our experience, preop-
erative coil embolization of IMA and lumbar artery side
branches is technically possible in most patients and has
prevented endoleak at a median follow-up of 2 years.
Post-EVAR embolization of side branch endoleaks is tech-
nically more challenging with a lower success rate but can
result in aneurysm shrinkage if successful.
We thank Mr Patrick J. Kent, MCh, FRCSI, for his
support and the provision of patients for this study.
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